新光药业
(300519)
| 流通市值：19.39亿 | | | 总市值：27.18亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 290,631,157.54 | 306,321,596.05 | 560,282,924.88 | 503,416,125.46 |
| 交易性金融资产 | 400,000,000 | 370,000,000 | 170,000,000 | 185,000,000 |
| 应收票据及应收账款 | 13,036,320.47 | 10,831,408.99 | 7,860,335.88 | 11,800,922.88 |
| 应收账款 | 13,036,320.47 | 10,831,408.99 | 7,860,335.88 | 11,800,922.88 |
| 应收款项融资 | 702,383.22 | 274,738.7 | 723,142 | 777,484.3 |
| 预付款项 | 1,688,518.38 | 370,109.83 | 2,889,753.35 | 3,420,912.39 |
| 其他应收款合计 | 190,430.9 | 220,451.4 | 9,781.2 | 38,221.68 |
| 存货 | 60,455,474.58 | 61,596,098.12 | 49,402,199.45 | 69,337,496.63 |
| 其他流动资产 | 944,181 | 1,015,841.37 | 987,913.32 | 922,091.11 |
| 流动资产合计 | 767,648,466.09 | 750,630,244.46 | 792,156,050.08 | 774,713,254.45 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 21,514,953.28 | 21,677,474.2 | 21,341,852.9 | 21,420,408.13 |
| 固定资产 | 96,377,967.5 | 99,358,272.08 | 101,901,532.06 | 105,521,867.76 |
| 在建工程 | - | 419,822.06 | 542,436.51 | - |
| 无形资产 | 7,658,180.27 | 7,730,836.06 | 7,803,491.85 | 7,876,147.64 |
| 递延所得税资产 | 206,576.88 | 123,077.77 | 188,643.46 | 249,657.39 |
| 非流动资产合计 | 125,757,677.93 | 129,309,482.17 | 131,777,956.78 | 135,068,080.92 |
| 资产总计 | 893,406,144.02 | 879,939,726.63 | 923,934,006.86 | 909,781,335.37 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 46,870,306.5 | 51,359,739.65 | 50,291,005.97 | 56,008,538.21 |
| 应付账款 | 46,870,306.5 | 51,359,739.65 | 50,291,005.97 | 56,008,538.21 |
| 合同负债 | 353,790.84 | 454,814.21 | 2,554,722.2 | 70,141.12 |
| 应付职工薪酬 | 764,575.92 | 738,597.52 | 679,906.89 | 3,172,247.18 |
| 应交税费 | 7,826,095.78 | 3,762,463.13 | 5,957,111.88 | 7,178,146.72 |
| 其他应付款合计 | 1,382,631.26 | 955,797.09 | 814,662.85 | 4,167,182.37 |
| 其他流动负债 | 45,992.81 | 59,125.85 | 332,113.89 | 9,118.35 |
| 流动负债合计 | 57,243,393.11 | 57,330,537.45 | 60,629,523.68 | 70,605,373.95 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 5,851,993.15 | 5,588,770.56 | 5,935,257.96 | 6,281,745.36 |
| 非流动负债合计 | 8,214,379.61 | 7,951,157.02 | 8,297,644.42 | 8,644,131.82 |
| 负债合计 | 65,457,772.72 | 65,281,694.47 | 68,927,168.1 | 79,249,505.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 3,386,453.34 | 3,524,596.13 | 3,239,318.03 | 3,306,089.98 |
| 盈余公积 | 116,924,680.74 | 116,924,680.74 | 116,924,680.74 | 116,924,680.74 |
| 未分配利润 | 386,348,202.7 | 372,919,720.77 | 413,553,805.47 | 389,012,024.36 |
| 归属于母公司股东权益合计 | 827,948,371.3 | 814,658,032.16 | 855,006,838.76 | 830,531,829.6 |
| 股东权益合计 | 827,948,371.3 | 814,658,032.16 | 855,006,838.76 | 830,531,829.6 |
| 负债和股东权益合计 | 893,406,144.02 | 879,939,726.63 | 923,934,006.86 | 909,781,335.37 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-28 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |